CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $63,000 | -65.0% | 52,609 | -47.2% | 0.00% | – |
| Q2 2022 | $180,000 | -90.9% | 99,690 | -89.8% | 0.00% | – |
| Q1 2022 | $1,969,000 | +46.0% | 974,210 | +95.7% | 0.00% | – |
| Q4 2021 | $1,349,000 | -41.4% | 497,877 | -3.6% | 0.00% | – |
| Q3 2021 | $2,304,000 | -53.2% | 516,628 | -39.1% | 0.00% | -100.0% |
| Q2 2021 | $4,919,000 | -1.8% | 848,171 | +18.9% | 0.00% | 0.0% |
| Q1 2021 | $5,007,000 | +73.2% | 713,231 | +18.5% | 0.00% | +100.0% |
| Q4 2020 | $2,891,000 | -33.0% | 602,078 | -18.6% | 0.00% | -50.0% |
| Q3 2020 | $4,312,000 | -12.6% | 739,556 | +1.2% | 0.00% | -50.0% |
| Q2 2020 | $4,931,000 | +14.8% | 730,500 | +8.2% | 0.00% | 0.0% |
| Q1 2020 | $4,294,000 | -27.7% | 675,187 | +18.5% | 0.00% | -55.6% |
| Q4 2019 | $5,939,000 | +5399.1% | 569,622 | +1959.8% | 0.01% | – |
| Q3 2019 | $108,000 | -81.9% | 27,654 | -31.0% | 0.00% | -100.0% |
| Q2 2019 | $596,000 | -70.4% | 40,086 | -50.6% | 0.00% | -66.7% |
| Q1 2019 | $2,014,000 | -1.1% | 81,139 | -28.5% | 0.00% | -40.0% |
| Q4 2018 | $2,037,000 | +86.5% | 113,409 | +204.9% | 0.01% | +150.0% |
| Q3 2018 | $1,092,000 | -58.7% | 37,195 | -36.1% | 0.00% | -66.7% |
| Q2 2018 | $2,645,000 | -49.5% | 58,178 | -41.4% | 0.01% | -57.1% |
| Q1 2018 | $5,242,000 | +2.6% | 99,285 | +32.2% | 0.01% | 0.0% |
| Q4 2017 | $5,107,000 | -42.9% | 75,101 | -30.8% | 0.01% | -50.0% |
| Q3 2017 | $8,940,000 | -47.6% | 108,488 | -40.4% | 0.03% | -53.3% |
| Q2 2017 | $17,046,000 | +220.7% | 182,054 | +118.0% | 0.06% | +160.9% |
| Q1 2017 | $5,316,000 | +38.0% | 83,494 | -3.7% | 0.02% | +35.3% |
| Q4 2016 | $3,851,000 | -19.1% | 86,700 | -34.3% | 0.02% | -26.1% |
| Q3 2016 | $4,759,000 | +1656.1% | 132,006 | +568.0% | 0.02% | +2200.0% |
| Q2 2016 | $271,000 | -78.2% | 19,762 | -69.5% | 0.00% | -85.7% |
| Q1 2016 | $1,242,000 | +63.6% | 64,700 | +198.4% | 0.01% | +75.0% |
| Q4 2015 | $759,000 | -84.5% | 21,682 | -59.3% | 0.00% | -86.7% |
| Q3 2015 | $4,895,000 | +338.6% | 53,220 | +319.1% | 0.03% | +328.6% |
| Q2 2015 | $1,116,000 | -85.4% | 12,700 | -87.7% | 0.01% | -88.1% |
| Q1 2015 | $7,647,000 | – | 103,025 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |